在阿尔茨海默病的NGF基胆固醇疗法在阿尔茨海默病
Sumonto Mitra1, Ruchi Gera1, Maria Eriksdotter2
1Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Handbook of clinical neurology
|May 8, 2025
概括
神经生长因子 (NGF) 通过恢复大脑的胆固醇系统,对阿尔茨海默病 (AD) 显示出有前途. NGF治疗旨在改善阿基胆的产生和AD患者的认知功能.
科学领域:
- 神经科学是一个神经科学.
- 神经生物学 神经生物学 神经生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆固醇系统对身体功能至关重要,它利用乙胆 (ACh) 进行信号传递.
- 胆固醇通路的失调与各种病理有关,特别是阿尔茨海默病 (AD).
- 神经生长因子 (NGF) 在调节胆固醇功能,包括细胞存活和ACh产生方面发挥着关键作用.
研究的目的:
- 探索NGF在调节中枢神经系统胆固醇系统中的作用.
- 研究NGF在阿尔茨海默氏病 (AD) 的治疗潜力.
- 审查NGF输送方法和AD治疗临床试验状态.
主要方法:
- 审查关于NGF,胆能信号传递和AD的现有文献.
- 分析NGF对基底前脑中胆性核的影响.
- 检查NGF输送技术和临床疗效数据.
主要成果:
- NGF对于胆固醇细胞的存活,ACH的产生和抗炎作用至关重要.
- 阿尔茨海默病的特点是基础前脑胆固醇核的早期退化,导致ACH缺乏.
- 胆酶抑制剂 (ChEIs) 是目前的AD治疗方法,但基于NGF的疗法提供了一个有前途的替代方案.
结论:
- 基于NGF的疗法对于恢复胆固醇神经元和恢复AD的认知功能至关重要.
- 将NGF有效地输送到大脑是成功治疗结果的关键.
- 目前正在进行的临床研究正在评估NGF在阿尔茨海默病治疗中的有效性.
更多相关视频
09:15Stereological Estimation of Cholinergic Fiber Length in the Nucleus Basalis of Meynert of the Mouse Brain
Published on: February 5, 2020
5.4K
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
11.8K
相关概念视频
01:22Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
562
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
562
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
625
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
625
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
983
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
983
01:24Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154